Sensors,
Год журнала:
2024,
Номер
24(4), С. 1250 - 1250
Опубликована: Фев. 15, 2024
The
total
number
of
confirmed
cases
COVID-19
caused
by
SARS-CoV-2
virus
infection
is
over
621
million.
Post-COVID-19
syndrome,
also
known
as
long
COVID
or
long-haul
COVID,
refers
to
a
persistent
condition
where
individuals
experience
symptoms
and
health
issues
after
the
acute
phase
COVID-19.
aim
this
study
was
assess
strength
fatigue
skeletal
muscles
in
people
recovered
from
A
94
took
part
cross-sectional
study,
with
45
participants
(referred
Post-COVID
Cohort,
PCC)
49
healthy
age-matched
volunteers
(Healthy
Control
HCC).
This
research
article
uses
direct
dynamometry
method
provide
detailed
analysis
post-COVID
survivors’
power
characteristics.
Biodex
System
4
Pro
utilized
evaluate
muscle
characteristics
during
test.
work
extensors
flexors
significantly
higher
PCC.
PCC
showed
less
both
compared
HCC.
In
conclusion,
provides
compelling
evidence
impact
post-COVID-19
on
performance,
highlighting
importance
considering
these
effects
rehabilitation
care
recovering
virus.
achieved
lower
values
than
The Neuroscientist,
Год журнала:
2023,
Номер
30(4), С. 421 - 439
Опубликована: Сен. 11, 2023
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2),
the
causative
agent
of
disease
2019
(COVID-19),
could
affect
brain
structure
and
function.
SARS-CoV-2
can
enter
through
different
routes,
including
olfactory,
trigeminal,
vagus
nerves,
blood
immunocytes.
may
also
from
peripheral
a
disrupted
blood-brain
barrier
(BBB).
The
neurovascular
unit
in
brain,
composed
neurons,
astrocytes,
endothelial
cells,
pericytes,
protects
parenchyma
by
regulating
entry
substances
blood.
astrocytes
highly
express
angiotensin
converting
enzyme
(ACE2),
indicating
that
BBB
be
disturbed
lead
to
derangements
tight
junction
adherens
proteins.
This
leads
increased
permeability,
leakage
components,
movement
immune
cells
into
parenchyma.
cross
microvascular
an
ACE2
receptor–associated
pathway.
exact
mechanism
dysregulation
COVID-19/neuro-COVID
is
not
clearly
known,
nor
development
long
COVID.
Various
biomarkers
indicate
severity
neurologic
complications
COVID-19
help
objectively
diagnose
those
developing
review
highlights
importance
disruption,
as
well
some
potentially
useful
COVID-19,
COVID/neuro-COVID.
Sensors,
Год журнала:
2023,
Номер
23(6), С. 2887 - 2887
Опубликована: Март 7, 2023
The
established
efficacy
of
electronic
volatile
organic
compound
(VOC)
detection
technologies
as
diagnostic
tools
for
noninvasive
early
COVID-19
and
related
coronaviruses
has
been
demonstrated
from
multiple
studies
using
a
variety
experimental
commercial
devices
capable
detecting
precise
mixtures
VOC
emissions
in
human
breath.
activities
numerous
global
research
teams,
developing
novel
electronic-nose
(e-nose)
methods,
have
generated
empirical
laboratory
clinical
trial
test
results
based
on
the
different
types
host
VOC-biomarker
metabolites
specific
chemical
classes.
COVID-19-specific
biomarkers
are
derived
disease-induced
changes
metabolic
pathways
by
SARS-CoV-2
viral
pathogenesis.
unique
mechanisms
proposed
recent
researchers
to
explain
how
causes
damage
organ
systems
throughout
body
associated
with
symptom
combinations,
cytokine
storms
physiological
cascades
that
disrupt
normal
biochemical
processes
through
gene
dysregulation
generate
disease-specific
targeted
e-nose
detection.
This
paper
reviewed
methods
applications
VOC-detection
early,
diagnosis
infections.
In
addition,
metabolomic
(quantitative)
biomarkers,
consisting
host-derived
VOCs
identified
exhaled
breath
patients,
were
summarized
possible
sources
useful
confirming
supporting
diagnoses.
Scientific Reports,
Год журнала:
2024,
Номер
14(1)
Опубликована: Апрель 2, 2024
Abstract
This
study
investigated
long
COVID
of
patients
in
the
Montefiore
Health
System
COVID-19
(CORE)
Clinics
Bronx
with
an
emphasis
on
identifying
health
related
social
needs
(HRSNs).
We
analyzed
a
cohort
643
CORE
(6/26/2020–2/24/2023)
and
52,089
non-CORE
patients.
Outcomes
included
symptoms,
physical,
emotional,
cognitive
function
test
scores
obtained
at
least
three
months
post-infection.
Socioeconomic
variables
median
incomes,
insurance
status,
HRSNs.
The
was
older
age
(53.38
±
14.50
vs.
45.91
23.79
years
old,
p
<
0.001),
more
female
(72.47%
56.86%,
had
higher
prevalence
hypertension
(45.88%
23.28%,
diabetes
(22.86%
13.83%,
COPD
(7.15%
2.28%,
asthma
(25.51%
12.66%,
lower
incomes
(53.81%
43.67%,
1
st
quintile,
unmet
(29.81%
18.49%,
0.001)
compared
to
survivors.
reported
wide
range
severe
long-COVID
symptoms.
HRSNs
experienced
worse
ESAS-r
(tiredness,
wellbeing,
shortness
breath,
pain),
PHQ-9
(12.5
(6,
17.75)
7
(2,
12),
GAD-7
(8.5
(3,
15)
4
(0,
9),
without.
Patients
outcomes
those
Journal of Personalized Medicine,
Год журнала:
2024,
Номер
14(2), С. 170 - 170
Опубликована: Янв. 31, 2024
Postural
orthostatic
tachycardia
syndrome
(POTS)
is
a
common
accompaniment
of
variety
chronic,
inflammatory
diseases,
including
long
COVID,
as
are
small,
insoluble,
'fibrinaloid'
microclots.
We
here
develop
the
argument,
with
accompanying
evidence,
that
fibrinaloid
microclots,
through
their
ability
to
block
flow
blood
microcapillaries
and
thus
cause
tissue
hypoxia,
not
simply
correlated
but
in
fact,
by
preceding
it,
may
be
chief
intermediary
POTS,
which
body's
exaggerated
'physiological'
response
hypoxia.
Similar
reasoning
accounts
for
symptoms
bundled
under
term
'fatigue'.
Amyloids
known
membrane
disruptors,
when
targets
nerve
membranes,
this
can
explain
neurotoxicity
hence
autonomic
nervous
system
dysfunction
contributes
POTS.
Taken
together
view,
we
indicate
microclots
serve
link
POTS
fatigue
COVID
manner
at
once
both
mechanistic
explanatory.
This
has
clear
implications
treatment
such
diseases.
Brain Disorders,
Год журнала:
2023,
Номер
10, С. 100074 - 100074
Опубликована: Апрель 5, 2023
The
coronavirus
disease
(COVID-19)
continues
to
spread
worldwide.
It
has
a
high
rate
of
delirium,
even
in
young
patients
without
comorbidities.
Infected
required
isolation
because
the
infectivity
and
virulence
COVID-19.
prevalence
delirium
COVID-19
primarily
results
from
encephalopathy
neuroinflammation
caused
by
acute
respiratory
distress
syndrome
(ARDS)-associated
cytokine
storm.
Acute
been
linked
psychotic
symptoms
subacute
phase
(4
12
weeks),
termed
post-acute
(PACS),
brain
fog,
cognitive
dysfunction,
fatigue,
"long
COVID,"
which
persists
beyond
weeks.
However,
no
review
article
that
mentions
"COVID-19
delirium"
have
never
reported.This
narrative
summarizes
data
on
associated
with
severe
2
(SARS-CoV-2)
infection
related
neurological
persistent
post-infection
illness
(PACS
or
long
COVID)
after
persistence
dysfunction.
Thus,
we
describe
pathophysiological
hypothesis
its
continuation
as
COVID.
This
also
describes
treatment
complicated
pneumonia.SARS-CoV-2
is
delirium.
An
association
between
Alzheimer's
suggested,
studies
are
being
conducted
multiple
facets
including
genetics,
cytology,
postmortem
study.This
suggests
important
short
long-term
neuropsychiatric
effects.
Several
hypotheses
proposed
highlight
potential
neurobiological
mechanisms
causal
factors,
neuronal-inflammatory
pathways
storm
cellular
senescence,
chronic
inflammation.
Clinical Microbiology Reviews,
Год журнала:
2024,
Номер
37(4)
Опубликована: Сен. 18, 2024
SUMMARYSARS-CoV-2
can
not
only
cause
respiratory
symptoms
but
also
lead
to
neurological
complications.
Research
has
shown
that
more
than
30%
of
SARS-CoV-2
patients
present
neurologic
during
COVID-19
(A.
Pezzini
and
A.
Padovani,
Nat
Rev
Neurol
16:636-644,
2020,
https://doi.org/10.1038/s41582-020-0398-3).
Increasing
evidence
suggests
invade
both
the
central
nervous
system
(CNS)
(M.S.
Xydakis,
M.W.
Albers,
E.H.
Holbrook,
et
al.
Lancet
20:
753-761,
2021
https://doi.org/10.1016/S1474-4422(21)00182-4
)
peripheral
(PNS)
(M.N.
Soares,
M.
Eggelbusch,
E.
Naddaf,
J
Cachexia
Sarcopenia
Muscle
13:11-22,
2022,
https://doi.org/10.1002/jcsm.12896),
resulting
in
a
variety
disorders.
This
review
summarized
CNS
complications
caused
by
infection,
including
encephalopathy,
neurodegenerative
diseases,
delirium.
Additionally,
some
PNS
disorders
such
as
skeletal
muscle
damage
inflammation,
anosmia,
smell
or
taste
impairment,
myasthenia
gravis,
Guillain-Barré
syndrome,
ICU-acquired
weakness,
post-acute
sequelae
were
described.
Furthermore,
mechanisms
underlying
SARS-CoV-2-induced
discussed,
entering
brain
through
retrograde
neuronal
hematogenous
routes,
disrupting
normal
function
cytokine
storms,
inducing
cerebral
ischemia
hypoxia,
thus
leading
Moreover,
an
overview
long-COVID-19
is
provided,
along
with
recommendations
for
care
therapeutic
approaches
experiencing
Journal of Affective Disorders,
Год журнала:
2024,
Номер
354, С. 679 - 687
Опубликована: Март 23, 2024
Suboptimal
health
status
is
a
global
public
concern
of
worldwide
academic
interest,
which
an
intermediate
between
and
illness.
The
purpose
the
survey
to
investigate
relationship
anxiety
statuses
suboptimal
identify
central
symptoms
bridge
symptoms.
Scientific Reports,
Год журнала:
2025,
Номер
15(1)
Опубликована: Янв. 11, 2025
Abstract
A
substantial
proportion
of
patients
suffer
from
Post-COVID
Syndrome
(PCS)
with
fatigue
and
impairment
memory
concentration
being
the
most
important
symptoms.
We
here
set
out
to
perform
in-depth
neuropsychological
assessment
PCS
referred
Neurologic
clinic
compared
without
sequelae
after
COVID-19
(non-PCS)
healthy
controls
(HC)
decipher
prevalent
cognitive
deficits.
included
n
=
60
neurologic
symptoms,
15
non-PCS
controls.
Basic
socioeconomic
data
subjective
complaints
were
recorded.
This
was
followed
by
a
detailed
test
battery,
including
assessments
general
orientation,
motor
fatigue,
screening
depressive
anxiety
information
processing
speed,
concentration,
visuomotor
attention,
verbal
short-term
working
memory,
flexibility,
semantic
phonematic
word
fluency,
as
well
visual
functions.
had
more
significantly
higher
scores
levels
symptoms
Non-PCS
HC.
Deep
showed
that
performed
worse
in
deficits
impaired
mental
flexibility
an
executive
subfunction,
reactivity
(prolonged
reaction
time).
Multiple
regression
affected
speed;
depression
did
not.
Self-reported
deficits,
are
mirrored
performance
domains
memory.
The
present
results
should
be
considered
optimize
treatment
algorithms
for
therapy
rehabilitation
programs
Biomedicines,
Год журнала:
2025,
Номер
13(2), С. 421 - 421
Опубликована: Фев. 10, 2025
In
the
years
following
global
emergence
of
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2),
or
COVID-19,
researchers
have
become
acutely
aware
long-term
symptomology
associated
with
this
disease,
often
termed
long
COVID.
Long
COVID
is
pervasive
symptoms
affecting
multiple
organ
systems.
Neurocognitive
are
reported
by
up
to
40%
patients,
resultant
effects
loss
daily
functioning,
employment
issues,
and
enormous
economic
impact
high
healthcare
utilization.
The
literature
on
effective,
safe,
non-invasive
interventions
for
remediation
cognitive
consequences
scarce
poorly
described.
Of
specific
interest
narrative
review
identification
potential
COVID-associated
neurocognitive
deficits.
Articles
were
sourced
from
PubMed,
EBSCO,
Scopus,
Embase
Preferred
Reporting
Items
Systematic
Reviews
Meta-Analyses
(PRISMA)
guidelines.
published
between
dates
January
2020
30
June
2024
included
in
search.
Twelve
studies
review,
including
a
feasibility
study,
pilot
case
series,
an
observational
addition
three
randomized
clinical
trials
four
interventional
studies.
Overall,
treatment
such
as
training,
brain
stimulation
therapy,
exercise
rehabilitation,
targeted
pharmacological
intervention,
other
related
paradigms
show
promise
reducing
issues.
This
highlights
need
more
rigorous
experimental
designs
future
needed
fully
evaluate
persistent
deficits